Terms: = Uterine cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Prognosis
18 results:
1. High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity.
Wagh V; Menon S; Maheshwari A; Gupta S; Deodhar KK; Rekhi B
Indian J Pathol Microbiol; 2023; 66(4):829-833. PubMed ID: 38084541
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract] [Full Text] [Related]
3. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
Fong A; Offman S
Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
[TBL] [Abstract] [Full Text] [Related]
4. Myeloid sarcoma arising at the uterine cervix in a patient with intestinal Behçet's disease and concurrent myelodysplastic syndrome: A case report.
Choi HY; Pak MG; Park JW
Medicine (Baltimore); 2022 Oct; 101(43):e31559. PubMed ID: 36316914
[TBL] [Abstract] [Full Text] [Related]
5. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract] [Full Text] [Related]
6. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
[TBL] [Abstract] [Full Text] [Related]
7. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and
Pasha A; Kumbhakar DV; Doneti R; Kumar K; Dharmapuri G; Poleboyina PK; S K H; Basavaraju P; Pasumarthi D; S D A; Soujanya P; Arnold Emeson I; Bodiga V; Pawar SC
Oxid Med Cell Longev; 2021; 2021():6692628. PubMed ID: 33815659
[TBL] [Abstract] [Full Text] [Related]
9. Utility of
Verma A; Menon S; Rekhi B; Pai T; Maheshwari A; Ghosh J; Gupta S; Deodhar K
Indian J Cancer; 2019; 56(4):335-340. PubMed ID: 31607703
[TBL] [Abstract] [Full Text] [Related]
10. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].
Lax SF
Pathologe; 2019 Feb; 40(1):36-45. PubMed ID: 30694356
[TBL] [Abstract] [Full Text] [Related]
11. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
Tsuyoshi H; Yoshida Y
Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
[TBL] [Abstract] [Full Text] [Related]
12. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.
Lewis N; Soslow RA; Delair DF; Park KJ; Murali R; Hollmann TJ; Davidson B; Micci F; Panagopoulos I; Hoang LN; Arias-Stella JA; Oliva E; Young RH; Hensley ML; Leitao MM; Hameed M; Benayed R; Ladanyi M; Frosina D; Jungbluth AA; Antonescu CR; Chiang S
Mod Pathol; 2018 Apr; 31(4):674-684. PubMed ID: 29192652
[TBL] [Abstract] [Full Text] [Related]
13. uterine sarcoma Part II-uterine endometrial stromal sarcoma: The TAG systematic review.
Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
[TBL] [Abstract] [Full Text] [Related]
14. Gynecologic cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus.
Pautier P; Nam EJ; Provencher DM; Hamilton AL; Mangili G; Siddiqui NA; Westermann AM; Reed NS; Harter P; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S73-7. PubMed ID: 25341584
[TBL] [Abstract] [Full Text] [Related]
15. Endometrial stromal tumors: the new WHO classification.
Conklin CM; Longacre TA
Adv Anat Pathol; 2014 Nov; 21(6):383-93. PubMed ID: 25299308
[TBL] [Abstract] [Full Text] [Related]
16. Aggressive behavior and poor prognosis of endometrial stromal sarcomas with ywhae-FAM22 rearrangement indicate the clinical importance to recognize this subset.
Kruse AJ; Croce S; Kruitwagen RF; Riedl RG; Slangen BF; Van Gorp T; Van de Vijver KK
Int J Gynecol Cancer; 2014 Nov; 24(9):1616-22. PubMed ID: 25244606
[TBL] [Abstract] [Full Text] [Related]
17. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and ywhae-FAM22 translocation status as predictors of survival.
Gremel G; Liew M; Hamzei F; Hardell E; Selling J; Ghaderi M; Stemme S; Pontén F; Carlson JW
Int J Cancer; 2015 Apr; 136(7):1608-18. PubMed ID: 25130488
[TBL] [Abstract] [Full Text] [Related]
18. [Therapy-related leukemia with t(8;21) initially diagnosed as mds (RAEB in T)].
Hanamura A; Ichikawa A
Rinsho Ketsueki; 1995 Aug; 36(8):755-61. PubMed ID: 7563609
[TBL] [Abstract] [Full Text] [Related]
